{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:44:14Z","timestamp":1792511054563,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.amjcard.2024.05.004","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T02:44:18Z","timestamp":1715309058000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["P2Y12 Inhibitor Monotherapy After Short-Term Dual Antiplatelet Therapy in Acute Coronary Syndrome"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5660-782X","authenticated-orcid":false,"given":"Sahib","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakash","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya S","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Bliden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Dawn","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Gurbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2024.05.004_bib0001","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart Disease and Stroke Statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0002","first-page":"e4","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0003","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018481","article-title":"Premature discontinuation of dual antiplatelet therapy after coronary stenting in veterans: characteristics and long-term outcomes","volume":"10","author":"Kinlay","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0005","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/heartjnl-2016-309509","article-title":"International patterns of dual antiplatelet therapy duration after acute coronary syndromes","volume":"103","author":"Bueno","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0006","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4244\/EIJ-D-22-00135","article-title":"Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised one-month DAPT trial","volume":"18","author":"Lee","year":"2022","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0007","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0008","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamacardio.2021.5244","article-title":"STOPDAPT-2 ACS Investigators. Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: the STOPDAPT-2 ACS randomized clinical trial","volume":"7","author":"Watanabe","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013242","article-title":"Short-term DAPT and DAPT de-escalation strategies for patients with acute coronary syndromes: a systematic review and network meta-analysis","volume":"16","author":"Kuno","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0010","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.123.064264","article-title":"Comparison of 3- to 6-month versus 12-month dual antiplatelet therapy after coronary intervention using the contemporary drug-eluting stents with ultrathin struts: the HOST-IDEA Randomized Clinical Trial","volume":"147","author":"Han","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0011","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/CIRCULATIONAHA.123.066943","volume":"149","author":"Hong","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0012","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0013","series-title":"Vol. 5 (RevMan 5) (computer program). version 5.4","year":"2020"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0014","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamacardio.2019.3355","article-title":"Benefit and risks of aspirin in addition to ticagrelor in acute coronary syndromes: A post hoc analysis of the randomized GLOBAL LEADERS trial","volume":"4","author":"Tomaniak","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0015","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1001\/jama.2019.8146","article-title":"SMART-CHOICE Investigators. Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial","volume":"321","author":"Hahn","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0016","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1093\/eurheartj\/ehaa670","article-title":"Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS","volume":"41","author":"Baber","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0017","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1038\/s41598-023-30597-w","article-title":"Incidence and predictors of cardiovascular outcomes after acute coronary syndrome in a population-based cohort study","volume":"13","author":"Ulvenstam","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014672","article-title":"Pericoronary adipose tissue attenuation in patients with acute coronary syndrome versus stable coronary artery disease","volume":"16","author":"Kuneman","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0019","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(18)30493-8","article-title":"6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial","volume":"391","author":"Hahn","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0020","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0021","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/ph16020232","article-title":"P2Y12 Inhibitor monotherapy versus conventional dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention: a meta-analysis","volume":"16","author":"Feng","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0022","first-page":"574","article-title":"Safety and efficacy of ticagrelor monotherapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: an individual patient data meta-analysis of TWILIGHT and TICO randomized trials","volume":"149","author":"Baber","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0023","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4244\/EIJ-D-22-00886","article-title":"Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the optica study","volume":"19","author":"van der Sangen","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0024","first-page":"e19549","article-title":"Duration of dual antiplatelet therapy after stent implantation, still an enigma: a systematic review of randomized clinical trials","volume":"13","author":"Aslam Zahid","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0025","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.120.046308","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0026","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0140-6736(20)30315-9","article-title":"Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis","volume":"395","author":"Chiarito","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.amjcard.2020.04.027","article-title":"Meta-analysis of dual antiplatelet therapy versus monotherapy with P2Y12 inhibitors in patients after percutaneous coronary intervention","volume":"127","author":"Malik","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0028","doi-asserted-by":"crossref","first-page":"12608","DOI":"10.1038\/s41598-023-39213-3","article-title":"P2Y12 inhibitor monotherapy after complex percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials","volume":"13","author":"Sotomi","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0029","doi-asserted-by":"crossref","first-page":"n1332","DOI":"10.1136\/bmj.n1332","article-title":"P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials [published correction appears in BMJ 2022;376:o239]","volume":"373","author":"Valgimigli","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2024.05.004_bib0030","unstructured":"ClinicalTrials.gov. PercutaNEOus Coronary Intervention Followed by Monotherapy Instead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: the NEO-MINDSET Trial (NEOMINDSET). Available at: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04360720. Accessed on November 5, 2023."},{"key":"10.1016\/j.amjcard.2024.05.004_bib0031","unstructured":"ClinicalTrials.gov. Sequential Monotherapy of TicagrElor and Clopidogrel After Coronary Intervention (MATE). Available at: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04937699. Accessed on November 5, 2023."},{"key":"10.1016\/j.amjcard.2024.05.004_bib0032","unstructured":"ClinicalTrials.gov. 1-Month DAPT Plus 5-Month Ticagrelor Monotherapy Versus 12-Month DAPT in Patients With Drug-Coated Balloon (CAGEFREEII). Available at: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04971356. Accessed on November 5, 2023."}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924003576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924003576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T01:00:42Z","timestamp":1721178042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914924003576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":32,"alternative-id":["S0002914924003576"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.05.004","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P2Y12 Inhibitor Monotherapy After Short-Term Dual Antiplatelet Therapy in Acute Coronary Syndrome","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}